WA19926

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WA19926, covering 2016-09-22 to 2016-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis [Phase 3]